Drug Shortage Report for AURO-NEVIRAPINE
| Report ID | 211613 |
| Drug Identification Number | 02318601 |
| Brand name | AURO-NEVIRAPINE |
| Common or Proper name | AURO-NEVIRAPINE |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NEVIRAPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60's |
| ATC code | J05AG |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-11-27 |
| Actual start date | |
| Estimated end date | 2024-03-31 |
| Actual end date | 2024-02-26 |
| Shortage status | Resolved |
| Updated date | 2024-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2024-02-27 | English | Compare |
| v11 | 2024-02-26 | French | Compare |
| v10 | 2024-02-26 | English | Compare |
| v9 | 2023-12-28 | French | Compare |
| v8 | 2023-12-28 | English | Compare |
| v7 | 2023-12-28 | French | Compare |
| v6 | 2023-12-28 | English | Compare |
| v5 | 2023-12-18 | French | Compare |
| v4 | 2023-12-18 | English | Compare |
| v3 | 2023-11-28 | English | Compare |
| v2 | 2023-11-27 | French | Compare |
| v1 | 2023-11-27 | English | Compare |
Showing 1 to 12 of 12